READE is a Service Disabled Veteran Owned Small Business (SDVOSB) global distributor of higher technology specialty chemical solids. READE offers a complete range of toll processing services such as:...
Article - 17 May 2004
A team of chemists has developed a unique new coating for inorganic particles at the nanoscale that may be able to disguise the particles as proteins. Posted April 29 2004
News - 27 Feb 2007
Brightly fluorescent quantum dots and quantum rods are quickly becoming important tools for identifying specific molecules and cells in living systems. Two new reports demonstrate some of the ways in...
News - 21 Apr 2008
Quantum dots have shown promise as ultrabright contrast agents for use in a variety of cancer imaging studies. Now, a team of investigators at the Multifunctional Nanoparticles in Diagnosis and...
News - 1 Mar 2016
Chemists in Syracuse University’s College of Arts and Sciences have made a transformational advance in an alternate lighting source—one that doesn’t require a battery or a...
News - 17 Jul 2008
A unique nanoparticle system developed by University at Buffalo scientists takes advantage of the versatility of bioconjugated quantum rods to ferry novel diagnostic and therapeutic agents across the...
News - 6 Feb 2007
Though there is little doubt that nanoscale devices are going to play a critical role in improving cancer detection and treatment over the next five to ten years, nanoparticles are already having a...
News - 4 May 2010
Quantum Polymers today announced the introduction of Quantano® extruded stock shape plastic products made with TEGO™ polymers, featuring carbon nanotube technology, manufactured by Entegris...
Article - 27 Aug 2005
Nanostructures, with their quantum properties, can be used in many industries, especially the electronics and energy sectors. The classification, composition and properties of inorganic nanostructures...
News - 26 Oct 2010
Though targeted nanoparticle-based imaging agents and therapeutics for diagnosing and treating cancer are making their way to and through the clinical trials process, researchers still do not have a...